M&A Deal Summary

Donaldson Acquires Isolere

On February 21, 2023, Donaldson acquired life science company Isolere

Acquisition Highlights
  • This is Donaldson’s 2nd transaction in the Life Science sector.
  • This is Donaldson’s 10th transaction in the United States.
  • This is Donaldson’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2023-02-21
Target Isolere
Sector Life Science
Buyer(s) Donaldson
Deal Type Add-on Acquisition

Target

Isolere

Research Triangle Park, North Carolina, United States
Isolere is an early-stage biotechnology company that develops novel and proprietary IsoTag reagents and accompanying filtration processes used for the purification and streamlined manufacturing of biopharmaceuticals. Its reagents are designed to substantially improve product quality and purity with faster timelines compared to competing solutions, enabling accelerated and more affordable delivery of life-changing therapies to patients globally. Isolere is based in Research Triangle Park, North Carolina.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Donaldson

Bloomington, Minnesota, United States
Category Company
Founded 1915
Sector Machinery
Employees13,000
Revenue 3.4B USD (2023)
DESCRIPTION
Donaldson's corporate headquarters in Minneapolis, Minnesota.
Donaldson's corporate headquarters in Minneapolis, Minnesota.

Donaldson is a provider of filtration systems and replacement parts. Donaldson is a technology-driven company committed to satisfying customer needs for filtration solutions through innovative research and development. Donaldson serves customers in the industrial and engine markets, including dust collection, power generation, specialty filtration, compressed air purification, off-road equipment, industrial compressors, heavy trucks and light vehicles. Donaldson was incorporated in 1915 and is based in Bloomington, Minnesota.

DEAL STATS #
Overall 15 of 17
Sector (Life Science) 2 of 3
Type (Add-on Acquisition) 12 of 13
State (North Carolina) 1 of 1
Country (United States) 10 of 10
Year (2023) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-14 Purilogics

Greenville, South Carolina, United States

Purilogics is an early-stage biotechnology company that leverages a novel technology platform for the development of best-in-class membrane chromatography products. The company offers a broad portfolio of purification tools for a wide range of biologics, including mRNA, plasmid DNA, viral particles, monoclonal antibodies, and proteins. Its proprietary formulations and processes create membranes that have significant competitive advantages, enabling faster and more cost-effective production of increasingly complex biologic drugs. Purilogics was formed in 2013 and is based in Greenville, South Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-06-29 Univercells

Nivelles, Belgium

Univercells is a producer of innovative biomanufacturing solutions for cell and gene therapy research, development and commercial manufacturing. The Company offers a comprehensive technology portfolio leveraging the strengths of process intensification and chaining as a direct answer to the growing demand of viral vectors and viral vaccines. Univercells is based in Nivelles, Belgium.

Buy -
Mergr

Product

Company

Legal